ddp4 inhibitors and glp 1 GLP-1 Series Part 1: Utilization drives decline in DPP-4 inhibitors, increase in SGLT2s among competitive drug classes Dipeptidyl peptidase-4 enzyme in diabetes

Aim for a sustained weight reduction of 10% to manage many obesity-related diseases or complications

Skinny shot

In the main per-protocol analyses, participants were followed from the index date to first mutually exclusive incidence of SIS, discontinuation of study drug (defined as more than 60 days without drug supply), initiation of other study drug, or switch to other glucose-lowering drug (defined as filling a prescription for any glucose-lowering drug other than the baseline treatment or metformin and not refilling the assigned drug for 60 days), death, or end of follow-up

Vitamin C serums are popular for their skin brightening effects

It was an impressive achievement